Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could you skip some optician visits? new study aims to find out

NCT ID NCT07370168

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to figure out the best schedule for follow-up visits for people who wear contact lenses. Researchers will track 300 healthy adults aged 18 to 40 who are new or experienced lens wearers. The goal is to see if fewer visits can still keep eyes safe and comfortable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to clearer guidelines on how many optician visits are needed for safe and convenient contact lens care.
What could go wrong
This is an observational study, not testing a new treatment. Results may not apply to all lens types or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

United Kingdom Specsavers

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age between 18 to 40 years * Willing to use the prescribed soft daily disposable contact lenses * Normal ocular health * Rx range from +8.00 to -12.00DS and up to 2.50DC (within range that could be fitted by CV 1 day CLs) * Willing to provide written consent in English * Can attain good vision: Best-corrected visual acuity of 6/12 or better in each eye * Have no history of ocular surgery, injury, recent or current infection within the last 3 months * Have no known allergies to the study products * Willing to attend the scheduled study visits and adhere to instructions * If taking fish oil or tear supplements, should have started at least 3 months prior to starting the study and not planned changes to supplement intake during the study Exclusion Criteria: * RGP, Extended Wear (re-usable), presbyopic, therapeutic/cosmetic, or myopia control contact lens wear * Experienced contact lens wearer with a history of regular lens wear more than 3 months * Unstable refractive error * Binocular vision anomaly not controlled by contact lenses * Patients require Presbyopic correction or age more than 40 years * Age \< 18 years old * Not on a stable medication * Participation in another clinical trial within 2 weeks of participation in this study * History or presence of any ocular disorder or condition in either eye that would likely interfere with the interpretation of the study results or patient safety * Self-reported pregnancy or lactation * Any ocular or systemic condition that may contradict contact lens wear \*\* \*The investigator has the right to exclude any patient's participation in the study if he/she deems it to be in the best interest of the patient. Minor exceptions to the inclusion / exclusion criteria will be submitted to, and considered by, the Pl and approved as required. This includes 'drop-outs' that subsequently return to contact lens wear during the study trial. * OO/CLO (ECP) Clinical Judgement

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Specsavers

    Birmingham, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.